USAID鈥檚 Reaching Impact Saturation and Epidemic Control (RISE) program has supported almost 25 countries across the globe with technical assistance, service delivery, research, and cross-cutting health system aid. RISE utilizes proven tactics from 20 years of PEPFAR implementation to address critical HIV and COVID-19 priorities and to further meet the demands of the Global Health Security Agenda. RISE is a multi-year project running through 2025, with an award ceiling of $391 million.
Timely, flexible and culturally
appropriate COVID-19 interventions.
Capacity building to Prevent, Detect,
and Respond to emerging health threats.
Prevent HIV Transmission with CAB-LA
The RISE provider toolkit is a vital resource to introduce CAB-LA to PrEP providers in PEPFAR-supported countries. It is designed to help clinicians learn about and support provision of CAB-LA as a new biomedical HIV prevention option.
Visit the RISE COVID-19 webpage for technical briefs, job aides and other resources created by RISE teams across the globe
RISE advances HIV epidemic control through prevention, care and treatment. In December of 2022, 29.8 million people were accessing antiretroviral therapy, up from less than 8 million in 2010. New HIV infections have been reduced by 59%, and AIDS-related deaths reduced by 69% since their peak. RISE continues to contribute to this astounding legacy of progress.
Index Testing for HIV Case Finding Proven Ways to Include MenRISE stands ready to support stakeholders to prepare for and remediate public health emergencies of international concern.
Kenya Leads in Basic Emergency Care Ecuador鈥檚 COVID-19 Laboratory ResponseSystem-focused strategies that are responsive, holistic and flexible in the face of each country鈥檚 specific circumstances.
RISE Responds in Rwanda Hypoxia in Emergency CareRISE is funded with support from the U.S. President’s Emergency Plan for AIDS relief and the American Rescue Plan Act, through the United States Agency for International Development, under the terms of the cooperative agreement 7200AA19CA00003. The contents are the responsibility of the RISE program and do not necessarily reflect the views of USAID or the United States Government.